Vimarsana
Biggest News Aggregation in the World

Prof Madhi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prof Madhi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prof Madhi Today - Breaking & Trending Today

30 COVID untruths that MUST be investigated – Dr EV Rapiti - Vimarsana News

30 COVID untruths that MUST be investigated – Dr EV Rapiti

Rapiti lists 30 COVID untruths about the narrative, messages and advice about COVID and the vaccines that need to be investigated.

COVID-19 measures with little protection should be scrapped, says Madhi - Vimarsana News

COVID-19 measures with little protection should be scrapped, says Madhi

Professor of Vaccinology Shabir Madhi stated that COVID-19 measures that serve no purpose should be dropped.

Behind South Africa's slow Covid vaccine rollout - Vimarsana News

Behind South Africa's slow Covid vaccine rollout

BBC News By Pumza Fihlani image copyrightAFP image captionPresident Cyril Ramaphosa was among the first to be vaccinated in February but since then the rollout has hit problems South Africa was swift to impose a strict lockdown and rigorous testing at the start of the coronavirus pandemic, but its vaccination programme can best be described as stuttering - despite it having the worst mortality rate on the African continent. In January, the country appeared to be finally out of the blocks - and faster than other African countries when it came to getting hold of the vaccines - but the rollout h...

Source: bbc.co.uk
Covid vaccine in South Africa: Behind the slow rollout - Vimarsana News

Covid vaccine in South Africa: Behind the slow rollout

The country has Africa's worst mortality figures but its vaccination programme lags behind others.

Source: bbc.com
Covid-19: S Africa stops use of AstraZeneca jab over failure to protect against variant - Vimarsana News

Covid-19: S Africa stops use of AstraZeneca jab over failure to protect against variant

Result from clinical trial comes nearly week after 1m doses of vaccine arrived in country